(Q56992312)

English

A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease

article

Statements

A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease (English)
0 references
0 references
0 references
0 references
0 references
0 references
0 references
Mark R Fleisher
0 references
Jewel Johanns
0 references
Marion Blank
0 references
October 2008
0 references
135
0 references
1130-41
0 references
4
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit